from Today's Healthcare News -- ScienceDaily http://ift.tt/1LVPX3I
Our mission is to advice, and to make the people of the world healthier through the power of information.
Rare cancer responds unusually well to new treatment: Results from the NETTER-1 trial
Results from a multi-center randomized international trial of an innovative treatment show a marked improvement in the length of time patients with mid-gut neuroendocrine tumors live without the disease getting worse.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1LVPX3I
from Today's Healthcare News -- ScienceDaily http://ift.tt/1LVPX3I
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment